Survey on the correlation between drinking habits and plasma cell-free DNA concentrations
Not Applicable
- Conditions
- Healthy subjects
- Registration Number
- JPRN-UMIN000048947
- Lead Sponsor
- Asahi Quality & Innovations, Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 98
Inclusion Criteria
Not provided
Exclusion Criteria
1) Subject who tests positive for hepatitis B antigen test. 2) Subject who has blood collection or donation more than 200mL within the past 1 month or more than 400mL within the past 3 months from the day of the start of the study. 3) Subject who is considered as an inappropriate candidate by the doctor in charge.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Specific blood test(cell-free DNA), drinking habits
- Secondary Outcome Measures
Name Time Method (Secondary outcomes) Blood biochemistry test, lactic acid, pyruvic acid, amino acid, ADH1B and ALDH2 gene polymorphisms, smoking habits, exercise habits (Safety evaluation) adverse events
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular pathways link alcohol consumption to plasma cell-free DNA release in healthy individuals?
How does alcohol intake compare to other lifestyle factors in influencing cfDNA concentrations in observational studies?
What biomarkers predict cfDNA concentration variations in JPRN-UMIN000048947's alcohol habit study?
Can plasma cfDNA levels serve as a biomarker for alcohol-induced health risks in asymptomatic individuals?
What are the key findings from Asahi Quality & Innovations' study on alcohol's impact on plasma cfDNA dynamics?